Methotrexate

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
Stanley B Cohen, Ronald F van Vollenhoven, Kevin L Winthrop, Cristiano A F Zerbini, Yoshiya Tanaka, Louis Bessette, Ying Zhang, Nasser Khan, Barbara Hendrickson, Jeffrey V Enejosa, Gerd R Burmester

Annals of the Rheumatic Diseases Mar 2021, 80 (3) 304-311; DOI: 10.1136/annrheumdis-2020-218510
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Elise van Mulligen, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219499; DOI: 10.1136/annrheumdis-2020-219499
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland
Aron Hjalti Bjornsson, Gerdur Grondal, Mar Kristjansson, Thorunn Jonsdottir, Thorvardur Jon Love, Bjorn Gudbjornsson

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219564; DOI: 10.1136/annrheumdis-2020-219564
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
Elise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, N H A M Denissen, Andreas H Gerards, Mike H de Jager, Wai-Kwan Lam-Tse, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong, Jolanda J Luime

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1550-1556; DOI: 10.1136/annrheumdis-2020-217528
Biologics, spondylitis and COVID-19
James Todd Rosenbaum, Hedley Hamilton, Dongseok Choi, Michael H Weisman, John D Reveille, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1663-1665; DOI: 10.1136/annrheumdis-2020-217941
Response to: ‘Correspondence on ‘Tapering towards DMARD-free remission in rheumatoid arthritis’ by Garcia et al
Elise van Mulligen, Pascal Hendrik Pieter de Jong

Annals of the Rheumatic Diseases Nov 2020, annrheumdis-2020-219293; DOI: 10.1136/annrheumdis-2020-219293
Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’
Ran Cui, Qiang Tong, Zhi-Yong Chen, Miao Chen, Sheng-Ming Dai

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-219173; DOI: 10.1136/annrheumdis-2020-219173
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive
Mandy Greenwood, Muhammad Shipa, Su-Ann Yeoh, Euthalia Roussou, Dev Mukerjee, Michael R Ehrenstein

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1516-1517; DOI: 10.1136/annrheumdis-2020-217725
Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’
Young Ho Lee

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218856; DOI: 10.1136/annrheumdis-2020-218856
Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al
Elise van Mulligen, Pascal H P de Jong

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218731; DOI: 10.1136/annrheumdis-2020-218731

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages